side effects from tirzepatide Comparative safety and of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide Side Effects: Timeline, Symptoms,

Not suitable for everyone.

In the SURPASS-4 trial, patients receiving tirzepatide experienced an average weight loss of 7.1 kg (15.7 lbs) after 52 weeks, compared to 2.5 kg (5.5 lbs) in the insulin glargine group[6]. The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes

Naturally optimize your appetite, cravings and metabolic efficiency for effortless weight loss without medications

However, its also known to cause a less-than-ideal side effect: diarrhea

Zepbound (tirzepatide) targets weight loss through GLP-1 and GIP receptors, but emerging research suggests potential mood and anxiety benefits beyond the scale

Semaglutide: Safe